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Lung cancer metastasisCigarette smoking is not only a documented risk for lung carcinogenesis but also promotes lung cancer devel-
opment. Nicotine, a major component of cigarette smoke but not a carcinogen by itself, has been found to in-
duce proliferation, invasion and metastasis of non-small cell lung cancer (NSCLC). Here we reported that
proinvasive effect of nicotine is analogous to that of hypoxia and involves stabilization and activation of
hypoxia-inducible factor (HIF)-1α, a key factor in determining the presence of HIF-1 and expression of its
downstreammetastasis-associated genes. Furthermore, nicotine-induced upregulation of HIF-1αwas depen-
dent on mitochondria-derived reactive oxygen species (ROS). Ecotopic expression of mitochondrial targeted
catalase effectively prevented nicotine-induced accumulation of HIF-1α protein. In addition, we demonstrat-
ed that the effect of nicotine in upregulation of HIF-1α was mediated by Dihydro-β-erythroidine (DhβE)-
sensitive nicotine acetylcholine receptors (nAChRs) and required synergistic cooperation of Akt and
mitogen-activated protein kinase (MAPK) pathways. These results suggest that exposure to nicotine could
mimic effects of hypoxia to stimulate HIF-1α accumulation and activity that might underlie the high meta-
static potential of lung cancer.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Lung cancer is leading cause of cancer-related death worldwide,
with more than 1 million deaths every year [1]. Lack of effective
tools for early diagnosis and highly metastatic potential might
account for the marked lethality of lung cancer, with a overall 5-
year mortality rate of still nearly 85% [2].
Cigarette smoke is the most established risk factor for lung cancer
and is highly correlated with the onset of non-small cell lung cancer,
which represents approximately 80% of all lung cancers [3]. In
addition to its documented risks for lung carcinogenesis, cigarette
smoking has been implicated in cancer development. However, the
molecular mechanisms underlying its role in cancer progression
are still poorly understood. Nicotine, a major component of cigarette
smoke and not a carcinogen by itself, has been implicated in the
progression and metastasis of lung cancer. Experimental evidence
demonstrated exposure to nicotine and its derivatives like 4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N′-
nitrosonornicotine (NNN) increases proliferation, invasion and
epithelial-mesenchymal transition of NSCLC cell lines [4–6]. Theion of China (30973384).
x: +86 022 60363013.
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l rights reserved.pathophysiological effects of nicotine and its derivatives are believed
to be mediated by nicotinic acetylcholine receptors (nAChRs) in target
cells, and in lung cancer predominantly by alpha7- and DhβE-
sensitive subtypes of nAChRs [7,8]. The interaction of nicotine with
nAChR has been found to increase oxidative stress and activate NF-κB
andmultiple signaling pathways that regulate the progression, growth,
and metastasis of tumors [9,10].
Metastasis is a major step in disease progression and over 90%
cancer deaths can be attributed to tumor metastasis [11]. It has
been suggested that the acquisition of metastatic phenotype is
achieved mainly through intratumoral hypoxia [12], which favor se-
lection of more aggressive and invasive cells within tumor mass and
therefore drive cancer progression [13]. To a large extent, many of
these cellular responses to hypoxia are mediated by the transcription-
al factor hypoxia-inducible factor 1 (HIF-1). HIF-1 consists of an
inducible alpha subunit (HIF-1α) and constitutively expressed β sub-
unit (HIF-1β), which heterodimerize and bind to hypoxia response
elements (HREs) in promoter region of numerous metastasis-
associated genes [14,15]. HIF-1α is continuously synthesized and
degraded during normoxia. The degradation of HIF-1α is triggered
by oxygen-dependent hydroxylation of two proline residues by a
family of prolyl hydroxylase (PHD) enzymes. Aside from oxygen-
dependent regulation of HIF-1α, the increase in HIF-1α levels is also
regulated by growth factor stimulation and free radicals generation.
Many lines of evidence indicate that levels of intracellular ROS were
closely linked to HIF-1α stabilization possibly through modiﬁcation
Table 1
Sequences of real-time RT-PCR primers.
Gene Genbank accession
number
Primer PCR product
(bp)
HIF-1α NM_001530 Forward:5′-tgatgaccagcaacttgagg-3′
Reverse:5′-tggggcatggtaaaagaaag-3′
166
VEGF NM_003376 Forward:5′-cccactgaggagtccaacat-3′
Reverse:5′-tttcttgcgctttcgttttt-3′
185
Glut-1 NM_006516 Forward:5′-cttcactgtcgtgtcgctgt-3′
Reverse:5′-tgaagagttcagccacgatg-3′
229
GAPDH NM_002046 Forward:5′-gaccccttcattgacctcaac-3′
Reverse:5′-cttctccatggtggtgaaga-3′
195
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main source of ROS production, appear to play a critical role in regu-
lation of HIF-1α stability in such a way that mitochondrial targeted
antioxidant prevents hypoxia-induced stabilization of HIF-1α protein
[17].
The ability of nicotine to drive acquisition of malignant phenotype
characterized by increased risk of metastasis is mostly similar for
hypoxia, given the fact that development of metastases of lung cancer
already started when the primary tumors are still small [2], we con-
jectured that exposure to nicotine might mimic the effects of hypoxia
to stimulate HIF-1 activity and thus promote the progression of lung
cancer. Indeed, a recent study showed that nicotine induced HIF-1α
expression in NSCLC cell lines [18]. However, the molecular pathways
underlying this observation have not been fully delineated. Therefore,
it was the aim of the present study to identify signaling cascades
and cellular processes that contribute to nicotine-induced HIF-1α
activation.
2. Methods
2.1. Reagents, cells, and transfections
Nicotine, N′-Nitrosonornicotine (NNN), 4-methylnitrosamino-1-
3-pyridinyl-1-butanone (NNK), Cobalt(II) chloride, and N-acetyl-L-
cysteine (NAC) were obtained from Sigma-Aldrich (St. Louis, MO). The
kinase inhibitors LY294002, PD98059, PP2, JNK inhibitor, and GSK-3β
inhibitor were purchased from Calbiochem and used at concentrations
of 20, 30, 30, 10, and 15 μM, respectively. All above concentrations
were found to be effective in previous studies [19–21]. Rotenone, diphe-
nyleneiodonium chloride (DPI), mecamylamine (MCA), methyllycaco-
nitine (MLA) and dihydro-β-erythroidine hydrobromide (DhβE) were
obtained from Sigma-Aldrich and concentrations of these inhibitors
used in this studywere referred to previous studies and titrated to effect
without toxicity. [22,23]. Anti-Hif-1α antibody was obtained from
Novus Biologicals (Littleton, CO), with anti-Hif-1β antibody obtained
from BD (Franklin Lakes, NJ). Anti-COXIV, anti-pAkt, anti-Akt, anti-
pErk, and anti-Erk antibody were purchased from Cell Signaling
(Beverly, MA), with Anti-Mn SOD from Stress Gene (Victoria, BC),
anti-human catalase from Athens Research Technology (Athens, GA).
Human A549 cells, NL-9980 cells, NCI-H466 cells and YTMLC-9 cells
were maintained in 1640medium supplemented with 10% fetal bovine
serum. For transfection, A549 cells were grown in six-well plates and
transfected with Lipofectamine™ LTX purchased from Invitrogen
(Carlsbad, CA) according to the manufacturer's instructions.
2.2. DNA constructs
The full-length superoxide dismutase 2 (SOD2) gene was generated
by PCR ampliﬁcation using cDNA from A549 cells as template and
primers: Forward: 5′-TAGAATTCATGTTGAGCCGGGCAGTGTGCGGCA-
3′, reverse: 5′-CTAAGCTTTTACTTTTTGCAAGCCATGTATCTT-3′. The
PCR products were digested with EcoRI and HindIII, and inserted
into pcDNA3.1 expression vector (Invitrogen). The mitochondria tar-
get catalase plasmid was kindly provided by Dr. Peter S. Rabinovitch
(Department of Pathology, University of Washington, Seattle).
2.3. Small interfering RNA (siRNA)
Chemically synthesized, double-stranded siRNA speciﬁcally target
human HIF-1a 5′-CUGAUGACCAGCAACUUGA dTdT-3′ and 5′-
UCAAGUUGCUGGUCAUCAG dTdT-3′ was obtained from Guangzhou
Ribobio Co. Ltd (Guangzhou, China). To provide a control, a
nontargeting siRNA was used for all experiments. A549 cells were
plated in 6-well plates and when cells were 30–50% conﬂuent, siRNAs
were added in ﬁnal concentration of 100 nMwith lipofectamine 2000
(Invitrogen) as per the manufacturer's instructions.2.4. Cytotoxicity detection
Cells were seeded in triplicate in 12-well plates and treated with
various concentrations of nicotine or 1% Triton X-100 as a positive
control for 3 h. The medium was collected and lactate dehydrogenase
(LDH) release into medium was detected by LDH cytotoxicity detec-
tion kit (Roche, Basel Switzerland) according to manufacturer's in-
structions. Data presented is a mean of 3 independent experiments.
2.5. Western blot analyses
A549 cells were seeded in 6-well plates (105 cells/well), and after
various treatments they were lysed in pre-warmed Laemmli buffer
purchased from Bio-Rad (Hercules, CA). For each sample the same
amount of total protein was added to a well of 10% acrylamide gel
and resolved by SDS-PAGE. A 1:800 dilution of anti-Hif-1α and Hif-
1β, and a dilution of 1:1000 dilution of all other primary antibodies
were used. Blots were quantiﬁed by densitometry using Transparency
Adapter (UTA-2100XL) for PowerLook 2100XL obtained from UMAX
(Mountain View, CA).
2.6. Determination of intracellular ROS levels
To measure the ROS, A549 cells were preincubated with 30 μM 2′,
7′-dichloroﬂuorescein diacetate (DCFDA, Sigma), an efﬁcient probe
for identiﬁcation of free radicals, especially H2O2 [24,25]. After
30 min, cells were harvested, washed and resuspended in PBS and
incubated with indicated concentrations of nicotine incubation for
1 h. Fluorescence intensity was detected by ﬂow cytometer (Cell Lab
QuantaTMSC, Beckman Coulter).
2.7. Quantitative real time RT-PCR
Total RNA was isolated at the indicated time using the RNA isola-
tion reagent TRIzol (Invitrogen). Reverse transcription was per-
formed by using the Reverse Transcriptase M-MLV (RNase H−) kit
(Takara Biotechnology, Dalian Co., Ltd). Each 25 μl of PCR reaction
mixture was prepared using the SYBR Premix Ex Taq™ Kit (TaKaRa).
The primer pairs used for each mRNA that was measured are shown
in Table 1. The ampliﬁcation conditions were according to the proto-
col of the SYBR Premix Ex Taq™ Kit. All the samples were performed
in triplicates in each experiment in 7500 Real Time PCR System
(Applied Biosystems, Foster city, CA). The relative amount mRNA
was calculated using the comparative CT method after normalization
to GAPDH mRNA levels.
2.8. Mitochondria isolations
A549 cells were plated in 6-well plates and transfection was done
with indicated amounts of SOD2 and mitochondrial targeted catalase
(MCAT) constructs using Lipofectamine™ LTX (Invitrogen). 72 h after
transfection, cells was exposed to nicotine for additional 3 h and
harvested. The mitochondria were isolated using the mitochondria
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facturers (PIERCE, Rockford, IL).
2.9. Chromatin immunoprecipitation (ChIP) assay
We used the ExactaChIP™ human/mouse HIF-1α Kit (R&D, Min-
neapolis, MN) to get the target DNA. Brieﬂy, A549 cells treated with
nicotine or NNK were crosslinked with 1% formaldehyde and
quenched by glycine. After washed with PBS, cells were scraped and
collected by centrifugation and cell pellets were lysed with kit provid-
ed lysis buffer. The resulting nuclear pellet was sonicated (Vibra
cell, SONICS, Newtown, CT) for four rounds of 15 pulses at 4% output
power and 70% duty to obtain average 1 kb sheared chromatin. The
sonicated lysates were used for immunoprecipitation with biotiny-
lated antibodies either against HIF-1α or normal goat IgG. The im-
mune complexes were recovered with magnetic streptavidin beads.
The immunoprecipitated DNA and input DNAwere extracted by incu-
bation with chelating Resin solution and boiled for 10 min to reverse
the cross-links. The DNA was puriﬁed with DNA puriﬁcation kit
(Qiagen). PCR was performed with puriﬁed DNA and recommended
reaction condition. The primers for human VEGF promoter are: for-
ward: 5′-CCTCAGTTCCCTGGCAACATCTG-3′ and reverse: 5′-GAA-
GAATTTGGCACCAAGTTTGT-3′.
2.10. Statistical analysis
Data are expressed as the mean (±S.D.), and statistical compari-
sons were done by analysis of variance (ANOVA) with Dunnett's cor-
rection for multiple comparisons using SAS version 9 (SAS Institute
Inc., Cary, NC) with pb0.05 considered statistically signiﬁcant.
3. Results
3.1. Nicotine increases levels of HIF-1α in a dose- and time-dependent
manner
Nicotine was recently reported to induce HIF-1α expression in
human NSCLC cells with 16 h exposure [18]. To explore the generality
of mode and kinetics of HIF-1 regulation by nicotine, we examined
the effect of nicotine on HIF-1 levels in NSCLC cell line A549
(human lung adenocarcinoma) across a range of concentrations and
durations of exposure. The cells were rendered quiescent by serum
starvation and subsequently treated with various concentrations
of nicotine for 3 h. Previous studies have shown that A549 cells
expressed the moderate basal levels of HIF-1α due to elevated glyco-
lytic metabolism in cancer cells [26], however, HIF-1α levels were
substantially elevated by nicotine treatment in a dose-dependent
manner (Fig. 1A). The maximal induction of HIF-1α by nicotine was
observed at 1 μM, which is physiologically relevant and can be
detected in the serum of those who smoke 1 pack a day [4]. The stim-
ulatory effect of nicotine on HIF-1α was not consistently observed at
higher dose (5 μM). However, the reduced effect of nicotine at higher
dose was not due to cytotoxicity as determined by analyzing lactate
dehydrogenase release in culture medium. The LDH levels did not
increase signiﬁcantly upon 5 μM nicotine stimulation compared
with low doses of nicotine treatment (Fig. 1B). The stimulatory effect
of nicotine on HIF-1α protein expression was further corroborated by
nicotine derivatives NNN and NNK. Exposure of A549 cells to either
NNN or NNK led to a signiﬁcant increase in HIF-1α levels at doses
that were seen with nicotine-mediated induction (Fig. 1C). Further-
more, both NNK and NNN treated cells exhibited more potent re-
sponse than nicotine treatment. To ensure our study relevant to
lung cancer and not speciﬁc to a single cancer cell line, we examined
the effect of nicotine on HIF-1α levels in a panel of human lung cancer
cells that originated from different histological entity. The western
blot of Fig. 1D showed that nicotine-induced HIF-1α expression wasalso evident in NL-9980 (human large cell lung cancer), NCI-H466
(human small cell lung cancer) and YTMLC-9 (human lung squamous
cell carcinoma) cells.
To determine the kinetics of HIF-1α expression regulated by nico-
tine, quiescent A549 cells were stimulated with 1 μM nicotine for
different time periods; The robust increase in levels of HIF-1α was
detected at the ﬁrst time point of 3 h, which was continuously sus-
tained over 8 h of nicotine stimulation, and then decayed as the dura-
tion of nicotine exposure increased to 24 h (Fig. 1E). Note treatment
of A549 cells with nicotine under various conditions did not affect
the levels of HIF-1β. The maximal increase in HIF-1α was observed
with 1 μM nicotine applied for 3 h, therefore, this condition was cho-
sen for experiments to elucidate the mechanism of nicotine-induced
up-regulation of HIF-1α protein.
3.2. Nicotine stimulates HIF-1-dependent transcriptional activity
To determine whether nicotine-induced up-regulation of HIF-1α
expression results in an increase in HIF-1 activity and HIF-1 regulated
gene expression, we ﬁrst performed quantitative real-time RT-PCR to
analyze the expression of two known HIF-1 target genes, VEGF and
glucose transporter-1 (Glut-1). As expected, treatment of quiescent
A549 cells with 1 μM nicotine showed a signiﬁcant increase in VEGF
and Glut-1 mRNA levels (Fig. 2A). We noticed that the increase was
statistically signiﬁcant but quantitatively small, possibly due to high
basal levels of HIF-1α protein in A549 cells. Interestingly, they were
reduced upon treatment with 5 μM nicotine, in which HIF-1α levels
and its targeted genes mRNA expression showed faithful dose-
dependent concordance. To conﬁrm that nicotine-induced upregula-
tion of VEGF and Glut-1 were indeed regulated by HIF-1α, we
employed RNA interference to silence HIF-1α expression in A549
cells. Fig. 2B showed a quantiﬁcation of mRNA by real-time RT-PCR
seventy-two hours after transfection of A549 cells with either siRNA
targeting HIF-1α or nontargeting control siRNA and subsequently
exposure to nicotine for 3 h. Compared to cells treated with control
siRNA, cells treated with HIF-1α siRNA showed a substantial decrease
in HIF-1α mRNA levels that was roughly 75% at 72 h post-
transfection. Furthermore, knockdown of HIF-1α transcripts by
siRNA was also accompanied by a signiﬁcant reduction of nicotine-
induced mRNA levels of VEGF and Glut-1. However, we noticed that
the basal levels of individual HIF-1 target genes seem to differ in
their response to HIF-1α silencing. HIF-1α siRNA treated cells had sig-
niﬁcantly less VEGF mRNA, but basal levels of Glut-1 mRNA were not
altered by knockdown of HIF-1α, suggesting that the mechanisms for
HIF-1-independent regulation of Glut-1 gene might be involved.
To further verify the direct involvement of HIF-1 in the observed
induction of VEGF expression by nicotine, ChIP assays were carried
out in A549 cells exposed either 1 μMnicotine or 1 μMNNK. Immuno-
precipitation with an antibody to HIF-1α revealed that HIF-1α anti-
bodies speciﬁcally immunoprecipitated the region of VEGF promoter
covering HIF-1 binding site and both nicotine and NNK treatment
signiﬁcantly increased the recruitment of HIF-1 into VEGF promoter
compared with untreated cells (Fig. 2C). Taken together, these exper-
iments indicated that up-regulation of HIF-1α by nicotine contributes
to its physiological effects.
3.3. Antioxidant reduces HIF-1α levels in nicotine-treated cells
In order to determine the mechanism for nicotine-induced upre-
gulation of HIF-1α, we ﬁrst verify whether the effect of nicotine on
HIF-1α levels was a consequence of change at mRNA expression
levels analyzed by quantitative RT-PCR. The result showed no notable
mRNA level changes of HIF-1α in A549 cells exposed to various con-
centrations of nicotine (Fig. 3A), suggesting the rate of synthesis is
not responsible for the increased levels of HIF-1α induced by nico-
tine. HIF-1α is composed of a hypoxia-inducible subunit (HIF-1α)
Fig. 1. Nicotine and its derivatives induce an increase in HIF-1α levels in a dose- and time-dependent manner. (A) Nicotine dose-dependently increased HIF-1α levels. A549 cells
were stimulated without or with 0.05–5 μM nicotine for 3 h. (B) Nicotine did not signiﬁcantly elicit cytotoxicity across a range of concentrations used. A549 cells were treated with
different concentrations of nicotine or 1% Triton X-100 as positive control for 3 h. Culture medium was collected for analyzing the released lactate dehydrogenase (LDH). The bars
represent the mean (±S.D.) calculated from three independent experiments done in triplicate. Although LDH levels increased upon nicotine treatment, compared with low doses of
nicotine treated cells, the LDH levels did not increase signiﬁcantly upon high doses of nicotine stimulation (*, pb0.05 for difference from untreated control by ANOVAwith Dunnett's
correction for multiple comparisons). (C) Induction of HIF-1α levels by nicotine's derivatives NNK and NNN. A549 cells were treated by different concentrations of NNK (upper
panel) or NNN (lower panel) for 3 h. Total cell lysates were subjected to western blot analysis using speciﬁc antibodies against HIF-1α. (D) Induction of HIF-1α by nicotine in dif-
ferent histological types of lung cancer cells. NL-9980 (human large cell lung cancer), NCI-H466 (human small cell lung cancer) and YTMLC-9 (human lung squamous carcinoma)
cells were treated by different concentrations of nicotine for 3 h. Total cell lysates were subjected to western blot analysis with HIF-1α antibody. (E) Time-course of induction of
HIF-1α by nicotine. A549 cells were treated without or with 1 μMnicotine for the indicated time and then lysed for western blot analysis using an antibody against HIF-1 α. The blot
membrane was then detected for HIF-1β expression using anti-HIF-1β antibodies. Endogenous β-actin expression levels serve as internal controls.
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of HIF-1 expression is mediated primarily through the post-
translational stabilization of HIF-1α subunit in response to hypoxia.
The similarity of pattern of HIF-1α induction by hypoxia and nicotine
suggested that there might exist the common biological regulatory
mechanisms between hypoxia and nicotine. To test this hypothesis,
we incubated A549 cells with a combination of nicotine and a
hypoxia-mimetic agent cobalt(II) chloride (CoCl2). Treatment of qui-
escent A549 cells with CoCl2 alone showed a clear dose-dependent
increase in HIF-1α levels (Fig. 3B). However, a combination of CoCl2
plus nicotine treatment exhibited the same pattern of HIF-1α levels
as CoCl2 alone, and nicotine did not additively enhance HIF-1α levels
induced by CoCl2 (Fig. 3C), implying two stimuli mediated their
effects of HIF-1α induction through the common mechanisms. If
each agent acting independently, one would have expected to see
the minimum additive effects after co-treatment of nicotine and
CoCl2.
CoCl2 was shown to mimic hypoxic response by inducing HIF-1α
stability through the generation of increased ROS levels duringnormoxia [27]. To determine whether the ROS was involved in
nicotine-induced upregulation of HIF-1α, A549 cells were pretreated
with ROS scavenger N-acetyl-L-cysteine (NAC), and then exposed to
nicotine for 3 h. As shown in Fig. 3D, HIF-1α induction by nicotine
was signiﬁcantly attenuated by antioxidant NAC in dose-dependent
fashion. Similarly, NAC efﬁciently suppressed NNK-induced HIF-1α
levels and eventually below the background levels (Fig. 3D, lower
panel). Moreover, NAC pretreatment decreased nicotine-induced
HIF-1α levels in various lung cancer cell lines (Fig. 3E), assuring the
involvement of ROS in nicotine- and its derivative NNK-mediated
upregulation of HIF-1α.
3.4. Mitochondrial ROS is required for nicotine-induced HIF-1α
upregulation
Recently, the connection between mitochondrial ROS and HIF-1α
stabilization has emerged [14,28]. In order to determine whether
mitochondrial ROS could mediate nicotine-induced upregulation of
HIF-1α, the cells were incubated with diphenylene (DPI), an inhibitor
Fig. 2. Nicotine treatment induces HIF-1-dependent transcriptional responses. (A) Nicotine increases levels of two known HIF-1 target genes. A549 cells were exposed to different
concentrations of nicotine (0, 1, 5 μM) for 3 h. Total RNA was isolated and cDNA was prepared. Quantitative real-time RT-PCR was done using primers for VEGF and Glut-1 genes.
Results are expressed as fold induction relative to cells without nicotine treatment after normalization to the GAPDH expression. The bars represent the mean (±S.D.) calculated
from three experimental values. (*, pb0.05 for difference from untreated control by ANOVA with Dunnett's correction for multiple comparisons). (B) Nicotine induces upregulation
of VEGF and Glut-1 is HIF-1 dependent. Forty-eight hours after transfection with HIF-1α or nontargeting control siRNA, A549 cells were placed on serum-free medium for 12 h and
then incubated with different concentrations of nicotine (0, 0.05, 1 μM) for 3 h. Quantitative real-time PCR was performed for the analysis of mRNA expression levels of HIF-1α,
VEGF and Glut 1 relative to internal control GAPDH. Reduction of HIF-1α levels signiﬁcantly decreases the expression of VEGF and Glut-1 mRNA. The bars represent the mean
(±S.D.) calculated from three experimental values. (*, pb0.05 for difference from untreated control by ANOVA with Dunnett's correction for multiple comparisons). (#, pb0.05
for difference from HIF-1α siRNA treated cells by ANOVA with Dunnett's correction for multiple comparisons). (C) Nicotine and NNK increases binding of HIF-1 to VEGF promoter.
A549 cells were incubated either with 1 μMnicotine or 1 μMNNK for 3 h and subjected to ChIP assays using anti-HIF-1 antibodies or control IgG. PCR using primers speciﬁc for VEGF
promoter showed the predicted 205 bp band for each sample. There was a striking increase in the recruitment of HIF-1 to VEGF promoter by nicotine and NNK.
856 L. Guo et al. / Biochimica et Biophysica Acta 1822 (2012) 852–861of NADPH oxidase enzymes that are major generators of non-
mitochondrial ROS, or rotenone, an inhibitor of mitochondrial elec-
tron transport chain. As shown in Fig. 4A, nicotine increased HIF-1α
levels in A549 cells, and this was not reduced by co-incubation with
DPI, instead the nicotine-induced increase was slightly increased by
20 μM DPI. In contrast, the addition of rotenone dose-dependently
abolished nicotine effect, suggesting mitochondrial ROS mediated
nicotine-induced HIF-1α upregulation.
To genetically address the role of mitochondrial ROS nicotine-
induced HIF-1α expression, transfection was performed to generate
cells with increased levels of superoxide dismutase 2 (SOD2), which
detoxiﬁes superoxide to hydrogen peroxide (H2O2) in mitochondria,
or mitochondrial catalase (MCAT), which is targeted to mitochondria
for speciﬁcally scavenging mitochondrial H2O2 [29]. The cells were
rendered quiescent 48 h after transfection and treated with 1 μM
nicotine for 3 h. The efﬁciency of transfection was determined by
preparing mitochondria fraction and by blotting either for COXIV,
which is mitochondrial protein, or for SOD2 and MCAT. Dose-
dependent increase of SOD2 levels strongly augmented the
nicotine-induced HIF-1α levels (Fig. 4B), strikingly, cells transfected
with a plasmid that expressed the mitochondria-targeted catalase
(MCAT) showed marked and dose-dependent decrease in the levels
of HIF-1α induced by nicotine (Fig. 4C). Taken together, the facts
that the ability of nicotine to stimulate HIF-1α is enhanced by SOD2
but diminished by catalase indicated H2O2 is central to the regulatorymechanism of nicotine-induced HIF-1α levels. Along these lines, the
ﬂuorescence probe DCFDA was used to monitor the intracellular gen-
eration of H2O2 in response to nicotine treatment [25]. Exposure of
A549 cells to nicotine resulted in a substantial increase in ﬂuorescent
intensity in dose-dependent manner (Fig. 4F), conﬁrming that the
presence of increased H2O2 induced by nicotine.
3.5. Akt and MAPK signaling pathways linking mitochondrial ROS to
HIF-1α accumulation
To further delineate the downstream signaling coupling mito-
chondrial ROS to the stabilization of HIF-1α, small molecule kinase
inhibitors were employed to determine whether activation of Akt,
MAPK, Src, JNK and GSK-3β, intracellular signaling pathways required
for stabilization of HIF-1α during hypoxia [17], was involved in ROS-
dependent stabilization of HIF-1α induced by nicotine. In contrast to
Src inhibitor and JNK inhibitor and GSK-3β inhibitor, which had no ef-
fect, the PI-3 kinase inhibitor LY294002 and MAPK inhibitor PD98059
caused substantial reduction of HIF-1α expression in the presence of
nicotine (Fig. 5A). The down-regulation of HIF-1α protein was not
caused by non-speciﬁc effects of inhibitors because treatment of
A549 cells with inhibitors alone, as shown in Fig. 5B, did not cause a
discernable decrease in the levels of HIF-1α. Furthermore, LY294002
appeared to synergize with PD98059 action, HIF-1α levels were
entirely abrogated by a combination of LY294002 and PD98059
Fig. 3. Reactive oxygen species were involved in nicotine-induced upregulation of HIF-1α levels. (A) Quantitative real-time PCR showed nicotine treatment of A549 cells with var-
ious concentrations for 3 h did not affect HIF-1α RNA levels. The bars represent the mean (±S.D.) calculated from three experimental values. (*, pb0.05 for difference from
untreated control by ANOVA with Dunnett's correction for multiple comparisons). (B) CoCl2 stimulated HIF-1α protein expression in a dose-dependent manner. A549 cells
were treated with increasing concentrations of CoCl2 for 3 h before western blot analysis using an anti-HIF-1α antibody. (C) Nicotine had no additive effect with CoCl2 on HIF-
1α levels. Western blot analysis of HIF-1α levels showed nicotine did not additively enhance CoCl2-induced HIF-1α expression in A549 cells exposed to nicotine (1 μM), CoCl2
(0.05 and 0.1 mM) or nicotine (1 μM) plus CoCl2 (0.05 and 1 mM) as indicated for 3 h. (D) Dose-dependent reduction of nicotine- and NNK-induced upregulation of HIF-1α levels
by antioxidants. A549 cells were pretreated with increasing concentrations of N-acetylcysteine (NAC) for 30 min before 1 μMnicotine (upper panel) or 1 μMNNK (lower panel) was
added. Western blot was conducted 3 h later to determine levels of HIF-1α. (Ε) Antioxidant NAC dose-dependently reduced HIF-1α levels in various lung cancer cell lines. NL-9980,
NCI-H466 and YTMLC-9 cells were treated with 1 μM nicotine with and without pretreatment of indicated amounts of NAC for 30 min. HIF-1α levels were determined by western
blot of total cell lysates.
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quired for maintaining a basal levels of HIF-1α expression. The partic-
ipation of Akt and MAPK pathways in nicotine-induced HIF-1α levels
was further supported by the fact that nicotine was able to stimulate
Akt and MAPK activity, as indicated by enhanced phosphorylation of
Akt and ERK (Fig. 5C, left panel). Interestingly, the most signiﬁcant in-
crease for both Akt and ERK phosphorylation was observed with 1 μM
nicotine application, the same dose as for maximal stimulation of HIF-
1α expression.
To extend our studies, we next asked if ROS could affect the ability
of nicotine to stimulate Akt andMAPK pathways, A549 cells were pre-
treated with antioxidant NAC and then exposed to nicotine for 3 h.
Antioxidant NAC dose-dependently decreased both Akt and ERK
phosphorylation (Fig. 5C, right panel). To further conﬁrm whether
mitochondrial ROS mediates nicotine-dependent induction of Akt
and MAPK activity, we ectopically overexpressed mitochondrial anti-
oxidant enzymes SOD2 and catalase, as shown in Fig. 5D, transient
transfection of SOD2 into A549 cells resulted in a dose-dependent in-
crease in nicotine-induced phosphorylation of Akt and ERK (left
panel), whereas dose-dependent increase of catalase levels signiﬁ-
cantly attenuated the levels of Akt and ERK phosphorylation induced
by nicotine (right panel), revealing the similar effect of antioxidantson nicotine-induced HIF-1α levels. Together, these results indicated
mitochondrial ROS plays a critical role in nicotine-induced HIF-1α
expression through Akt and MAPK pathways.3.6. Involvement of DhβE-sensitive nAChR in nicotine-induced HIF-1α
expression
Nicotine contributes to its physiological effects through stimula-
tion of nicotinic acetylcholine receptors (nAChRs) in target cells. It
was next examined whether the effect of nicotine on HIF-1α levels
required nAChR function. Toward this purpose, A549 cells were pre-
incubated with various receptor antagonists before stimulation with
1 μM nicotine. As shown in Fig. 6A and B, mecamylamine (MCA), a
general antagonist of nAChR, and Dihydro-β-erythroidine (DhβE),
an alpha4-speciﬁc nAChR antagonist, at 100 μM signiﬁcantly reduced
nicotine-induced upregulation of HIF-1α, whereas an antagonist of
alpha7-speciﬁc nAChRmethyllycaconitine (MLA) did not have any ef-
fect. To strengthen the above results, we examined the role of DhβE
on nicotine-induced activation of Akt and MAPK pathways. Again,
we observed a dose-dependent decrease of nicotine-induced phos-
phorylation of Akt and ERK by DhβE pretreatment (Fig. 6C). Taken
Fig. 4.Mitochondrial hydrogen peroxide mediated nicotine-induced HIF-1α levels. (A) The stimulatory effect of nicotine was inhibited by rotenone. A549 cells were pretreated with
NADPH oxidase inhibitor DPI (5 and 10 μM) andmitochondrial ROS inhibitor, rotenone (10 and 50 μM) for 30 min. Cells were then stimulated with 1 μMnicotine in the absence and
presence of inhibitors as above for 3 h. Western blot showed rotenone decreased nicotine-induced HIF-1α levels. (B and C) Hydrogen peroxide was required for accumulation of
HIF-1α levels induced by nicotine 48 h after transfection either with indicated amounts of SOD2 expression plasmids (B) or the plasmid containing mitochondrial targeted catalase
(MCAT) (C), A549 cells were starved with serum-free medium for 12 h and then incubated for 3 h with 1 μM nicotine. Mitochondria fractions were prepared and analyzed by west-
ern blot (bottom two panels) with an antibody against SOD2 (B), catalase (C) and mitochondrial protein COXIV (B and C) to determine the speciﬁcity and efﬁciency of transfection.
Western blot was also performed with antibodies against HIF-1α using whole cell lysates (top two panels) prepared from the same treatment as above. Nicotine-induced HIF-1α
levels was elevated in A549 cells upon transfection of SOD2, but was reduced in A549 cells transfected with catalase expression plasmid. (D and E) Densitometry conﬁrmed that
HIF-1α levels increased in A549 cells after transfected with increased amounts of SOD2 plasmids, but dose-dependently decreased in A549 cells transfected with mitochondrial
targeted catalase (MCAT) expression vectors. (F) Representative histogram of DCF ﬂuorescence. A549 cells were treated with indicated concentrations of nicotine for 1 h and
evaluated for DCFDA as a measure of intracellular H2O2.
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primarily mediated by DhβE-sensitive nAChR.
4. Discussion
Lung cancer is the most common cause of cancer-related deaths in
the world. Development of metastasis signiﬁcantly contributes to the
high mortality of this disease. In many cases, the metastases already
occurred by the time of diagnosis when the primary tumors are still
small. Although the mechanisms of high metastatic potential of lung
cancer remain unknown, mounting evidence support the idea that
metastasis of lung cancer is probably inﬂuenced by intrinsic proper-
ties such as dysregulated signaling pathways as well as extrinsic
properties such as communication with carcinogen-exposed micro-
environment especially in the context of cigarette smoking [30].
However, most studies have focused on the role of smoking in lung
carcinogenesis, the contribution of tobacco components to the lung
cancer metastasis is relatively unexplored. Previous study showed
that nicotine, an important component of cigarette smoking, canpromote HIF-1α protein accumulation in a receptor-dependent man-
ner [18], but the cellular processes mediating these events have not
been fully identiﬁed. In the present study, we have shown that expo-
sure to nicotine and its derivatives such as NNK can stimulate gener-
ation of mitochondrial ROS andmimic the effects of hypoxia to induce
HIF-1α accumulation and activity. Moreover, the present study
advances prior studies of nicotine by identifying Akt and MAPK as
the key mediator of mitochondrial ROS stimulated by nicotine and
upregulation of HIF-1α levels. These ﬁndings are likely to contribute
to our understanding the role of nicotine in metastatic processes of
lung cancer and give insight into novel therapies of lung cancer.
The role of HIF-1 in the development of metastatic diseases has
long been recognized. Studies have shown that levels of HIF-1 in-
creased with the progression of the pathological stage of tumors
and have been positively related to tumor aggressiveness and a
poor prognosis [31–34]. Aside from hypoxia, HIF-1α activity can
also be induced or enhanced by growth factors stimulation and ele-
vated reactive oxygen species (ROS) [14]. The recent discovery of
mitochondria to regulate HIF-1α protein further underscores the
Fig. 5. Inhibition of Akt andMAPK pathways reduced nicotine-induced upregulation of HIF-1α. (A) Effect of kinases inhibitors onHIF-1α levels induced by nicotine. Total cell lysateswere
prepared fromA549 cells cultured for 30 min in the presence of PI-3 kinase inhibitor (LY294002 at 20 μM), MEK inhibitor (PD98059 at 30 μM), Src inhibitor (PP2 at 30 μM), JNK inhibitor
(JNK inhibitor at 10 μM), and GSK-3β-inhibitor (GSK-3β-inhibitor at 15 μM) before exposure of cells to nicotine (1 μM) for an additional 3 h, and analyzed bywestern blot with anti-HIF-
1α. (B) Regulation of HIF-1α by LY294002 and PD98059. A549 cells were pretreated with kinases inhibitors, LY294002 (20 μM), PD98059 (30 μM) and LY294002 (20 μM) plus PD98059
(30 μM), for 30 min before treatment with 1 μMnicotine, and then subjected towestern blot analysis for HIF-1α levels. LY294002 has an additive effect with PD98059 to further diminish
HIF-1α levels. (C) Nicotine-induced activation of Akt andMAPK pathwayswas reduced by antioxidant N-acetylcysteine (NAC). Left panel indicated nicotine treatment induced activation
of Akt and MAPK signaling pathways in a dose-dependent manner. A549 cells were treated with indicated concentrations of nicotine for 30 min. Whole cell lysates were prepared and
analyzed for total protein levels and phosphorylated form of Akt and ERK, respectively. (Right panel) Total lysates were obtained from A549 cells pretreated for 30 min with different
concentrations of NAC before 1 μM nicotine was added. Western blot was conducted with antibodies against total- or phosphorylated-Akt and ERK. (D) Catalase and SOD2 modulated
nicotine-stimulated activation of Akt and MAPK pathways. A549 cells transfected either with SOD2 expression plasmid (1, 1.5, 2, 3 μg) (left panel), or plasmid containing mitochondrial
targeted catalase (1, 1.5, 2, 3 μg) (right panel) for 48 h prior to serum starvation and stimulation with 1 μM nicotine. Mitochondrial fraction (bottom two panels) and total cell lysates
(top four panels) were prepared and analyzed by western blot with antibodies against indicated proteins.
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Initial studies from Mansﬁeld et al. demonstrated that cells are not
able to stabilize HIF-1α protein during hypoxia when knocking out
the cytochrome c gene [35]. Complimentary ﬁndings using RNA inter-
ference have also shown that knockdown of the complex III subunit
Rieske iron sulfur protein (RISP) effectively prevents hypoxic stabili-
zation of HIF-1α protein [36], indicating mitochondrial electron
transport chain is necessary for stabilizing HIF-1α during hypoxia.
Paradoxically, mitochondrial electron transport chain increases the
production of ROS during hypoxia and these mitochondria-derived
ROS appear to be both necessary and sufﬁcient to stabilize HIF-1α
protein [17]. Indeed, studies from McCreath et al. showed cells
treated with the mitochondrial targeted antioxidant MITOQ result in
failure to stabilize the HIF-1α protein during hypoxia [37]. These ob-
servations lend strong support for a role of mitochondrial ROS in sta-
bilization of HIF-1α protein.
Multiple lines evidence indicate that nicotine increases oxidative
stress associated with cardiovascular, pulmonary and neoplastic dis-
orders [9]. In addition, nicotine has been shown to cause oxidative
stress to the pancreatic tissue of rats as demonstrated by increasing
free radical generation and lipid peroxidation [38]. However, the re-
sults of our study highlighted the essential role of mitochondrial
ROS induced by nicotine in triggering stabilization of HIF-1α. How
mitochondrial ROS is generated by nicotine is another important
issue. Previous studies observed the inhibitory effect of nicotine onmitochondrial respiratory chain [39,40]. This may be of potential rel-
evance taking in mind that disruption of mitochondrial respiratory
chain is likely to increase free radical production due to leakage of
electrons from respiratory complexes, an event that has been de-
scribed to occur under hypoxia condition [17]. Along these lines, a re-
cent study showed that neonatal exposure to nicotine signiﬁcantly
increases pancreatic ROS generation and protein carbonylation, par-
ticularly within mitochondrial fraction [41]. Nicotine exerts its biolog-
ical effects mainly through stimulation of the nicotinic acetylcholine
receptors (nAChRs), a family of ligand-gated Ca++ or Na+ ion chan-
nel receptors that mediate nicotine addiction in brain and prolifera-
tion, apoptosis, and migration of non-neuronal cells. Binding of
nicotine to nAChRs leads to increased levels of intracellular Ca++,
which in turn causes Ca++ ﬂux into mitochondria [8,9]. High levels
of Ca++ in the mitochondria activate mitochondrial metabolism.
There might be some mechanistic link between a rise in mitochondri-
al Ca++ concentration and an increase in ROS generation. The molec-
ular basis by which elevated Ca++ concentration increases
mitochondrial ROS production is worthy of future investigation.
Interestingly, in accordance with previous reports [4,42], our re-
sults indicated nicotine-induced HIF-1α levels was indeed mediated
by DhβE-sensitive nicotine acetylcholine receptors (nAChRs). How-
ever, studies from other labs also indicated the important role of
α7-nAChRs in mediating the pathophysiological effects of nicotine
[5,43]. Although such a discrepancy is not entirely clear at present,
Fig. 6. The effect of nicotine on HIF-1α.expression was mediated via DhβE-sensitive
nAChR. (A and B) A549 cells were pretreated with the increasing concentrations
of mecamylamine, a general antagonist of nAChR (A), or with DhβE (50 μM and
100 μM), α3- and α4-speciﬁc nAChR antagonist, or MLA (50 μM and 100 μM), α7-
speciﬁc antagonist (B), before 1 μM nicotine was added. Western blot was conducted
3 h later to determine HIF-1α levels. (C) Dose-dependent reduction of nicotine-
induced Akt and ERK activation by DhβE. A549 cells were pretreated with indicated
amounts of DhβE for 30 min before 1 μM nicotine was added. Blot was probed with
antibodies against phospho-Akt and phospho-ERK.
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tine are mediated by α7-nAChRs, whereas DhβE-sensitive nicotine
acetylcholine receptors mediates pro-survival effects of nicotine [8].
This may be relevant because elevated HIF-1α has been found to re-
sist to apoptosis by upregulation pro-survival gene expression [44].
Whether the pro-survival effects of nicotine are mediated through
HIF-1 deserves future study.
The speciﬁc signaling pathways linking mitochondrial ROS to HIF-
1α accumulation have also been addressed. In the present study, the
possibility that activation of Akt and MAPK pathways is required for
nicotine-induced HIF-1α stabilization was validated in two ways.
First, the blockade of Akt and ERK activation by kinases inhibitors
greatly decreased nicotine-induced HIF-1α levels. Moreover, the
levels of HIF-1α were totally abolished by combined PD98059 plus
LY290042 treatment, suggesting the requirement of synergistic coop-
eration between Akt and MAPK pathways for nicotine-induced HIF-
1α. Second, nicotine-induced activation of Akt and ERK was inhibited
by mitochondrial catalase but enhanced by SOD2, the same pattern as
nicotine-induced HIF-1α levels. Taken together, our results support a
major role of Akt and MAPK pathways in nicotine-induced HIF-1α in
NSCLC cell line. However, the possibility of indirect involvement of
other signaling pathways such as NF-κB and Src cannot be ruled out
in our study. The mechanisms of how Akt and MAPK prevent hydrox-
ylation of HIF-1α protein remain unknown.
The data reported herein that nicotine can mimic effects of hypox-
ia to increase the mitochondrial ROS production and in turn upregu-
late HIF-1α protein not only provide delineation of molecular
mechanisms underlying the high metastatic potential of lung cancer
but also a strong rationale for the development of novel approach
targeting the mitochondrial ROS to prevent HIF-1α activation. The
signiﬁcant work has recently been reported using three tumorigenic
animal models that antitumorigenic effects of antioxidants in vivoare indeed HIF-1 dependent [45], strongly supporting the potential
application of antioxidants in combating HIF-1 dependent NSCLC.
However, the mitochondrial targeted antioxidants that scavenge
ROS within mitochondria and do not affect the redox status of cytosol
might be a more valuable tool to ablate HIF-1 activity. Our results not
only established an important role of nicotine and its derivatives in
the development of lung cancer but also open a novel avenue for
therapy of cancers promoted by smoking.
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